Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization
Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and prevention of bleeds ...